XML 35 R22.htm IDEA: XBRL DOCUMENT v3.25.0.1
Accrued Expenses and Other Current Liabilities
 12 Months Ended
Dec. 31, 2024
Payables and Accruals [Abstract]  
Accrued Expenses and Other Current Liabilities ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
Accrued expenses and other current liabilities consisted of the following:
December 31,
(in thousands)20242023
Accrued payments due to AstraZeneca $12,077 $3,680 
Accrued gross to net revenue liabilities10,112 3,258 
Accrued sales and marketing expenses3,696 3,223 
Other8,757 4,880 
Total accrued expenses and other current liabilities$34,642 $15,041